new glp-1 medications What to Make of the Coverage and Cost Landscape FDA says that the GLP-1

Description

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

"Semaglutide and Renal Outcomes in Type 2 Diabetes." NEJM, 2022

Slow dose increases, dietary adjustments, hydration, and supportive care help ease the transition

The most commonly discussed skin-sagging side effect is "Ozempic face" a gaunt, jowly visage that can happen if certain patients lose volume in their face through rapid weight loss

The general clinical distinction between oral and transdermal (patch) estradiol is one of the more important conversations to have with a licensed provider before starting - and it's a conversation that telehealth providers should be equipped to have with you